Literature DB >> 22728444

The origin of genetic diversity in HIV-1.

Redmond P Smyth1, Miles P Davenport, Johnson Mak.   

Abstract

One of the hallmarks of HIV infection is the rapid development of a genetically complex population (quasispecies) from an initially limited number of infectious particles. Genetic diversity remains one of the major obstacles to eradication of HIV. The viral quasispecies can respond rapidly to selective pressures, such as that imposed by the immune system and antiretroviral therapy, and frustrates vaccine design efforts. Two unique features of retroviral replication are responsible for the unprecedented variation generated during infection. First, mutations are frequently introduced into the viral genome by the error prone viral reverse transcriptase and through the actions of host cellular factors, such as the APOBEC family of nucleic acid editing enzymes. Second, the HIV reverse transcriptase can utilize both copies of the co-packaged viral genome in a process termed retroviral recombination. When the co-packaged viral genomes are genetically different, retroviral recombination can lead to the shuffling of mutations between viral genomes in the quasispecies. This review outlines the stages of the retroviral life cycle where genetic variation is introduced, focusing on the principal mechanisms of mutation and recombination. Understanding the mechanistic origin of genetic diversity is essential to combating HIV.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728444     DOI: 10.1016/j.virusres.2012.06.015

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  49 in total

1.  Identifying recombination hot spots in the HIV-1 genome.

Authors:  Redmond P Smyth; Timothy E Schlub; Andrew J Grimm; Caryll Waugh; Paula Ellenberg; Abha Chopra; Simon Mallal; Deborah Cromer; Johnson Mak; Miles P Davenport
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

2.  Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.

Authors:  Daniel A Donahue; Sophie M Bastarache; Richard D Sloan; Mark A Wainberg
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

Review 3.  The high cost of fidelity.

Authors:  Sarah B Lloyd; Stephen J Kent; Wendy R Winnall
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01       Impact factor: 2.205

4.  Evaluation of anti-HIV-1 mutagenic nucleoside analogues.

Authors:  Valérie Vivet-Boudou; Catherine Isel; Yazan El Safadi; Redmond P Smyth; Géraldine Laumond; Christiane Moog; Jean-Christophe Paillart; Roland Marquet
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

5.  Clonality and intracellular polyploidy in virus evolution and pathogenesis.

Authors:  Celia Perales; Elena Moreno; Esteban Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-20       Impact factor: 11.205

Review 6.  Decoding HIV resistance: from genotype to therapy.

Authors:  Irene T Weber; Robert W Harrison
Journal:  Future Med Chem       Date:  2017-08-09       Impact factor: 3.808

7.  Tautomerism provides a molecular explanation for the mutagenic properties of the anti-HIV nucleoside 5-aza-5,6-dihydro-2'-deoxycytidine.

Authors:  Deyu Li; Bogdan I Fedeles; Vipender Singh; Chunte Sam Peng; Katherine J Silvestre; Allison K Simi; Jeffrey H Simpson; Andrei Tokmakoff; John M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

8.  The Molecular Characterization of Intestinal Explant HIV Infection Using Polymerase Chain Reaction-Based Techniques.

Authors:  Laura Janocko; Andrew D Althouse; Rhonda M Brand; Ross D Cranston; Ian McGowan
Journal:  AIDS Res Hum Retroviruses       Date:  2015-08-24       Impact factor: 2.205

Review 9.  Adaptive translation as a mechanism of stress response and adaptation.

Authors:  Tao Pan
Journal:  Annu Rev Genet       Date:  2013-08-28       Impact factor: 16.830

10.  Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients.

Authors:  Doreen Mhandire; Miguel Lacerda; Sandra Castel; Kudakwashe Mhandire; Danai Zhou; Marelize Swart; Tinei Shamu; Peter Smith; Tutsirai Musingwini; Lubbe Wiesner; Babill Stray-Pedersen; Collet Dandara
Journal:  OMICS       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.